Pulmonary hypertension, nephrotic syndrome, and polymyositis due to hepatitis C virus infection: A case report

被引:1
作者
Zhao, Ya-Nan [1 ]
Liu, Guo-Hui [1 ]
Wang, Chang [1 ]
Zhang, Yi-Xuan [1 ]
Yang, Ping [1 ]
Yu, Ming [1 ,2 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Cardiol, Changchun 130033, Jilin, Peoples R China
[2] Jilin Univ, China Japan Union Hosp, Dept Cardiol, 126 Xian tai St, Changchun 130033, Jilin, Peoples R China
关键词
Hepatitis C; Nephrotic syndrome; Polymyositis; Pulmonary hypertension; Case report; PORTOPULMONARY HYPERTENSION; MANAGEMENT; SURVIVAL;
D O I
10.3748/wjg.v29.i19.3040
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUNDHepatitis C infection not only damages the liver but also often accompanies many extrahepatic manifestations. Incidences of pulmonary hypertension (PH) caused by hepatitis C are rare, and incidences of concurrent nephrotic syndrome and polymyositis are even rarer.CASE SUMMARYHerein we describe the case of a 57-year-old woman who was admitted to our department for intermittent chest tightness upon exertion for 5 years, aggravated with dyspnea for 10 d. After relevant examinations she was diagnosed with PH, nephrotic syndrome, and polymyositis due to chronic hepatitis C infection. A multi-disciplinary recommendation was that the patient should be treated with sildenafil and macitentan in combination and methylprednisolone. During treatment autoimmune symptoms, liver function, hepatitis C RNA levels, and cardiac parameters of right heart catheterization were monitored closely. The patient showed significant improvement in 6-min walking distance from 100 to 300 m at 3-mo follow-up and pulmonary artery pressure drops to 50 mmHg. Long-term follow-up is needed to confirm further efficacy and safety.CONCLUSIONIncreasing evidence supports a relationship between hepatitis C infection and diverse extrahepatic manifestations, but it is very rare to have PH, nephrotic syndrome, and polymyositis in a single patient. We conducted a literature review on the management of several specific extrahepatic manifestations of hepatitis C.
引用
收藏
页码:3040 / 3047
页数:8
相关论文
共 20 条
[1]   Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection [J].
Aisa, Y ;
Yokomori, H ;
Kashiwagi, K ;
Nagata, S ;
Yanagisawa, R ;
Takahashi, M ;
Hasegawa, H ;
Tochikubo, Y .
INTERNAL MEDICINE, 2001, 40 (11) :1109-1112
[2]  
[Anonymous], 2018, BMJ CASE REP
[3]  
Bianchi Francesco B, 2007, Dig Liver Dis, V39 Suppl 1, pS22
[4]   Hepatitis C virus and autoimmunity [J].
Bockle, Barbara C. ;
Sepp, Norbert T. .
AUTOIMMUNITY HIGHLIGHTS, 2010, 1 (01) :23-35
[5]   Treatment of hepatitis C-related kidney disease [J].
Fabrizi, Fabrizio ;
Martin, Paul ;
Cacoub, Patrice ;
Messa, Piergiorgio ;
Donato, Francesca M. .
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (12) :1815-1827
[6]  
Galiè N, 2005, REV ESP CARDIOL, V58, P523
[7]   A global view of pulmonary hypertension [J].
Hoeper, Marius M. ;
Humbert, Marc ;
Souza, Rogerio ;
Idrees, Majdy ;
Kawut, Steven M. ;
Sliwa-Hahnle, Karen ;
Jing, Zhi-Cheng ;
Gibbs, J. Simon R. .
LANCET RESPIRATORY MEDICINE, 2016, 4 (04) :306-322
[8]  
Humbert M., 2023, EUR RESPIR J, V61
[9]   Portopulmonary Hypertension A Report From the US-Based REVEAL Registry [J].
Krowka, Michael J. ;
Miller, Dave P. ;
Barst, Robyn J. ;
Taichman, Darren ;
Dweik, Raed A. ;
Badesch, David B. ;
McGoon, Michael D. .
CHEST, 2012, 141 (04) :906-915
[10]   Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry [J].
Lazaro Salvador, Maria ;
Quezada Loaiza, Carlos A. ;
Rodriguez Padial, Luis ;
Barbera, Joan A. ;
Lopez-Meseguer, Manuel ;
Lopez-Reyes, Raquel ;
Sala-Llinas, Ernest ;
Alcolea, Sergio ;
Blanco, Isabel ;
Escribano-Subias, Pilar .
INTERNAL MEDICINE JOURNAL, 2021, 51 (03) :355-365